3
Clinical Trials associated with RGH-338An adaptive, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to examine the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of RGH-338 in healthy male volunteers. - First-in-Human study of RGH-338
Start Date12 Mar 2020 |
Sponsor / Collaborator- |
NL8930 / RecruitingNot Applicable An adaptive, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to examine the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of RGH-338 in healthy male volunteers.
Start Date09 Mar 2020 |
Sponsor / Collaborator- |
An adaptive, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to examine the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of RGH-338 in healthy male volunteers.
Start Date09 Mar 2020 |
Sponsor / Collaborator- |
100 Clinical Results associated with RGH-338
100 Translational Medicine associated with RGH-338
100 Patents (Medical) associated with RGH-338
100 Deals associated with RGH-338